PRICE T ROWE ASSOCIATES INC /MD/ - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$561
-90.2%
31,213
-88.9%
0.00%
-100.0%
Q2 2023$5,721
+12.2%
281,620
+0.7%
0.00%0.0%
Q1 2023$5,100
-51.2%
279,530
-44.7%
0.00%
-50.0%
Q4 2022$10,458
-98.3%
505,747
+2016.2%
0.00%
Q3 2022$626,000
+39.4%
23,899
+35.0%
0.00%
Q2 2022$449,000
-26.8%
17,701
-8.9%
0.00%
Q1 2022$613,000
-15.0%
19,437
+9.1%
0.00%
Q4 2021$721,000
+11.3%
17,815
-4.1%
0.00%
Q3 2021$648,000
+26.8%
18,584
-0.2%
0.00%
Q2 2021$511,000
-14.3%
18,623
-12.3%
0.00%
Q1 2021$596,000
+8.2%
21,235
-0.0%
0.00%
Q4 2020$551,000
+182.6%
21,244
+86.3%
0.00%
Q3 2020$195,000
-95.3%
11,402
-97.1%
0.00%
-100.0%
Q4 2018$4,171,000
-23.0%
387,312
-0.3%
0.00%0.0%
Q3 2018$5,414,000
-31.3%
388,390
-39.7%
0.00%0.0%
Q2 2018$7,884,000
-22.1%
644,090
-1.7%
0.00%
-50.0%
Q1 2018$10,120,000655,4380.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders